Rifabutin-induced cystoid macular oedema.
Détails
Etat: Public
Version: Final published version
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_40CAF71472F9
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Rifabutin-induced cystoid macular oedema.
Périodique
The Journal of Antimicrobial Chemotherapy
ISSN
0305-7453
Statut éditorial
Publié
Date de publication
02/2002
Peer-reviewed
Oui
Volume
49
Numéro
2
Pages
421-422
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Résumé
Rifabutin is a semi-synthetic antimycobacterial agent mainly used in the treatment of Mycobacterium avium-complex (MAC) in AIDS patients. Rifabutin-induced anterior uveitis has been reported previously. We report the case of a rifabutin-induced cystoid macular oedema (CMO) in an immunocompetent patient with pulmonary MAC infection. As far as we know, CMO secondary to rifabutin therapy has not been described previously.
Mots-clé
Anti-Bacterial Agents/adverse effects, Female, Humans, Macular Edema/chemically induced, Macular Edema/diagnosis, Middle Aged, Pulmonary Disease, Chronic Obstructive/drug therapy, Rifabutin/adverse effects
Pubmed
Web of science
Open Access
Oui
Création de la notice
28/01/2008 13:45
Dernière modification de la notice
14/02/2022 8:54
Données d'usage
